Vlieghe P - Search Results

1

Peptide-based vectors for blood-brain barrier targeting and delivery of drugs to the central nervous system.

Vlieghe P, Khrestchatisky M. Vlieghe P, et al. Ther Deliv. 2010 Oct;1(4):489-94. doi: 10.4155/tde.10.44. Ther Deliv. 2010. PMID: 22833961 Free article. No abstract available.

2

Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting.

Malcor JD, Payrot N, David M, Faucon A, Abouzid K, Jacquot G, Floquet N, Debarbieux F, Rougon G, Martinez J, Khrestchatisky M, Vlieghe P, Lisowski V. Malcor JD, et al. Among authors: vlieghe p. J Med Chem. 2012 Mar 8;55(5):2227-41. doi: 10.1021/jm2014919. Epub 2012 Feb 14. J Med Chem. 2012. PMID: 22257077

3

Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.

Vlieghe P, Khrestchatisky M. Vlieghe P, et al. Med Res Rev. 2013 May;33(3):457-516. doi: 10.1002/med.21252. Epub 2012 Mar 20. Med Res Rev. 2013. PMID: 22434495 Review.

4

Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos.

David M, Lécorché P, Masse M, Faucon A, Abouzid K, Gaudin N, Varini K, Gassiot F, Ferracci G, Jacquot G, Vlieghe P, Khrestchatisky M. David M, et al. Among authors: vlieghe p. PLoS One. 2018 Feb 27;13(2):e0191052. doi: 10.1371/journal.pone.0191052. eCollection 2018. PLoS One. 2018. PMID: 29485998 Free PMC article.

5

Synthetic therapeutic peptides: science and market.

Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Vlieghe P, et al. Drug Discov Today. 2010 Jan;15(1-2):40-56. doi: 10.1016/j.drudis.2009.10.009. Epub 2009 Oct 30. Drug Discov Today. 2010. PMID: 19879957 Review.

6

New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.

Vlieghe P, Bihel F, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Chermann JC, Kraus JL. Vlieghe P, et al. J Med Chem. 2001 Mar 1;44(5):777-86. doi: 10.1021/jm001033s. J Med Chem. 2001. PMID: 11262088

7

New 3'-azido-3'-deoxythymidin-5'-yl O-(4-hydroxyalkyl or -alkenyl or -alkylepoxide) carbonate prodrugs: synthesis and anti-HIV evaluation.

Vlieghe P, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Kraus JL. Vlieghe P, et al. J Med Chem. 2001 Aug 30;44(18):3014-21. doi: 10.1021/jm010863i. J Med Chem. 2001. PMID: 11520210

8

New bicyclam-AZT conjugates: design, synthesis, anti-HIV evaluation, and their interaction with CXCR-4 coreceptor.

Dessolin J, Galea P, Vlieghe P, Chermann JC, Kraus JL. Dessolin J, et al. Among authors: vlieghe p. J Med Chem. 1999 Jan 28;42(2):229-41. doi: 10.1021/jm980358u. J Med Chem. 1999. PMID: 9925728

9

Synthesis of new covalently bound kappa-carrageenan-AZT conjugates with improved anti-HIV activities.

Vlieghe P, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Kraus JL. Vlieghe P, et al. J Med Chem. 2002 Mar 14;45(6):1275-83. doi: 10.1021/jm010969d. J Med Chem. 2002. PMID: 11881996

10

Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs?

Anastasi C, Vlieghe P, Hantz O, Schorr O, Pannecouque C, Witvrouw M, De Clercq E, Clayette P, Dereuddre-Bosquet N, Dormont D, Gondois-Rey F, Hirsch I, Kraus JL. Anastasi C, et al. Among authors: vlieghe p. Bioorg Med Chem Lett. 2003 Aug 4;13(15):2459-63. doi: 10.1016/s0960-894x(03)00496-7. Bioorg Med Chem Lett. 2003. PMID: 12852943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page